HCI Equity Partners Selling SDS Rx To DHL Supply Chain

By Amit Chowdhry • Yesterday at 9:15 AM

HCI Equity Partners has announced that its portfolio company, Strategic Delivery Solutions (SDS Rx), has entered into a definitive agreement to be acquired by DHL Supply Chain, a division of DHL Group. The deal, expected to close by the end of 2025 pending customary approvals, will integrate SDS Rx’s specialized final-mile healthcare delivery services into DHL’s global life sciences and healthcare logistics network.

SDS Rx is a leading U.S. provider of time-critical, patient-focused deliveries for long-term care and specialty pharmacies, radiopharmacies, and health system networks. Operating from more than 200 locations nationwide, the company offers same-day and expedited delivery services designed to support quality of care for patients and operational efficiency for healthcare providers.

HCI Equity Partners, which has owned SDS Rx since 2017, views DHL as a strategic fit for the business. The acquisition will combine SDS Rx’s expertise in high-touch, last-mile healthcare logistics with DHL’s scale, infrastructure, and global reach. This alignment is expected to broaden service offerings across the healthcare value chain, enhance delivery reliability, and maintain the patient-first service model for which SDS Rx is known.

For SDS Rx employees and leadership, the transition is anticipated to provide continuity while offering the resources and opportunities that come with being part of a global organization. DHL’s investment in healthcare logistics has been growing, and the addition of SDS Rx will strengthen its ability to deliver integrated, end-to-end solutions for life sciences and healthcare customers.

After the transaction is complete, SDS Rx will operate under DHL’s ownership but continue its mission of delivering specialized, high-quality logistics solutions that directly support patient care. The move underscores the increasing importance of final-mile delivery in the healthcare sector, particularly as demand for specialty pharmacy services continues to rise.

KEY QUOTES:

“We are genuinely excited about the future of SDS under DHL’s ownership. This is a fantastic home for the business, and we’re confident SDS will thrive and accelerate realization of its exciting growth opportunities. HCI would like to thank the SDS leadership team and employees for their outstanding dedication and partnership during our ownership. Their hard work and commitment to excellence have been instrumental in positioning the company for this next chapter.”

Doug McCormick, Managing Partner at HCI Equity Partners